Fundraising September 15, 2024 – October 1, 2024 About fundraising

Single agent and synergistic activity of the "first in...

  • Main
  • 2016 / 08
  • Single agent and synergistic activity of the "first in...

Single agent and synergistic activity of the "first in class" dual PI3K/BRD4 inhibitor SF1126 with Sorafenib in hepatocellular carcinoma

Singh, A. R., Joshi, S., Burgoyne, A. M., Sicklick, J. K., Ikeda, S., Kono, Y., Garlich, J. R., Morales, G. A., Durden, D. L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0976
Date:
August, 2016
File:
PDF, 9.92 MB
english, 2016
Conversion to is in progress
Conversion to is failed